RSV Immunization Coverage Among US Infants Receiving Nirsevimab or Maternal Vaccination
How many infants are getting new RSV protection? A first look
An observational report describes RSV immunization coverage among US infants born from October 2023 to March 2024 who received nirsevimab mo…
For the first time, doctors have tools to protect youngest babies from RSV with new shots or pregnancy vaccines.
CDC recommends clesrovimab for preventing severe RSV lower respiratory infections in infants
CDC recommends new antibody to protect infants from severe RSV
The CDC has issued a recommendation for the use of clesrovimab to prevent severe respiratory syncytial virus-associated lower respiratory tr…
The CDC now recommends a new antibody to help protect infants from severe respiratory syncytial virus infections.
Case report: Initial positive measles IgM tests in two Samoan children were false positives
When a measles test says yes, could it really mean no?
An outbreak report describes two children in American Samoa with rash illness and initial positive measles IgM tests.
A positive measles test for two children in American Samoa turned out to be wrong, revealing other viruses can mimic the disease.
Palivizumab reduces medically attended RSV infections in preterm infants, shows similar efficacy to nirsevimab
Can an older RSV drug protect healthy preterm babies from doctor visits?
A meta-analysis of three randomized, placebo-controlled studies in 2,464 healthy infants born ≤35 weeks' gestational age found palivizumab r…
An older RSV shot cuts doctor visits for preterm babies by 70%, matching newer drugs, though safety details remain unclear.
Questions about Human Metapneumovirus Infection
What specific risks are associated with Human Metapneumovirus Infection in hospitalized children?
Hospitalized children with Human Metapneumovirus (HMPV) face high risks of severe pneumonia, wheezing, and co-infections, with infants and those with underlying health issues being most vulnerable.
Full answer →